[1]
M. F. Sagdic, E. Tunc, M. O. Kulturoglu, O. A. Yildirim, and L. Dogan, “HER2 IHC score as a predictor of pathologic complete response in HER2-positive breast cancer after neoadjuvant therapy”, Ann Med Res , vol. 33, no. 8, pp. 369–374, Aug. 2026, Accessed: Sep. 05, 2026. [Online]. Available: http://www.annalsmedres.org/index.php/aomr/article/view/4937